Seroprevalence of IgG antibodies against measles, mumps and rubella in Swiss children during the first 16 months of life;Seropravalenz von IgG-antikorpern gegen masern, mumps und roteln bei Schweizer kindern in den ersten 16 lebensmonaten

Schweizerische Medizinische Wochenschrift

Volumn 130, Issue 41, 2000, Pages 1479-1486

  Desgrandchamps, D ^a   Schaad, U B ^a   Glaus, J ^a   Tusch, G ^a   Heininger, U ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Immunisation; Measles; MMR; Mumps; Rubella; Seroprevalence

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MATERNAL ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNITY; INFANT; MAJOR CLINICAL STUDY; MEASLES; MUMPS; PASSIVE IMMUNIZATION; PRESCHOOL CHILD; RUBELLA; SEROPREVALENCE; SWITZERLAND; AGING; BLOOD; FEMALE; IMMUNOLOGY; NEWBORN; PATIENT SELECTION; PREGNANCY;

AGING; ANTIBODIES, VIRAL; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MEASLES; MUMPS; PATIENT SELECTION; PREGNANCY; RUBELLA; SWITZERLAND;

EID: 0034649023     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Der neue schweizerische Impfplan
2. Impfplan fur routinemassige Schutzimpfungen. Stand Dezember 1997
3. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program
4. Kleinkinderimpfungen. Reprasentative erhebung zur durchimpfung in der Schweiz 1998
5. Reduced measles immunity in infants in a well-vaccinated population
6. Persistence of maternal antibody in infants beyond 12 months: Mechanism of measles vaccine failure
7. Rubella, measles and mumps antibodies following immunisation in children
8. Further attenuated live measles vaccines: The need for revised recommendations
9. Epidemic measles in a highly vaccinated population
10. Measles vaccine efficacy: Influence of age at immunisation vs duration of time since immunisation
11. Additional evidence against measles vaccine administration to infants less than 12 months of age: Altered immune response following active and passive immunisation
12. Maternally derived measles immunity in the era of vaccine-protected mothers
13. A study of maternally derived measles antibody in infants born to naturally infected or vaccinated women
14. Transplacental measles immunity in infants in the 1st year of life
15. Passive immunity against measles during the first 8 months of life of infants born to vaccinated mothers or to mothers who sustained measles
16. Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity
17. Pravakzinale Antikorpertiter gegen Masern-, Mumps- und Rotelnviren im Sauglings- und fruhen Kleinkindesalter
18. Increased susceptibility to measles in infants in the United States
19. Recommended childhood immunisation schedule: United States, January 1995
20. Impfempfehlungen Stand Marz 1997
21. Vaccination and herd immunity to infectious diseases
22. Pravakzinale antikorpertiter gegen masern-, mumps- und rotelnviren im sauglings- und fruhen kleinkindesalter
23. Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses
24. Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines
25. Mumps-specific immunoglobulin M and G antibodies in natural mumps infection as measured by enzyme-linked immunosorbent assay
26. Masern, mumps und roteln: Durchimpfungsrate und seropravalenz bei 8.-Klasslern in acht verschiedenen orten der schweiz 1995/96
27. Altersabhangige seropravalenz von masern-, mumps- und rotelnantikorpern im jahr 1996
28. Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9-11, 12-14 or 15-17 months of age
29. Seroconversion of a trivalent measles, mumps, and rubella vaccine in children aged 9 and 15 months
30. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months